European Stocks Climb, Driven by Inditex and Novo Nordisk
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 10 2025
0mins
Should l Buy ORCL?
Source: Reuters
European Market Performance: European shares rose, with the pan-European STOXX 600 up 0.5% as retailers led gains, particularly Inditex, which reported improved sales, and Novo Nordisk, which announced job cuts to save costs.
Sector Highlights: The healthcare sector saw a slight increase, while tech stocks also performed well, buoyed by Oracle's strong cloud order projections. Meanwhile, Polish stocks fell due to geopolitical tensions following drone incidents.
Political Developments in France: France's CAC 40 index increased after President Macron appointed a new prime minister, amidst ongoing challenges in managing fiscal spending and anticipation of a credit rating decision from Fitch.
Upcoming Economic Indicators: Investors are awaiting the European Central Bank's monetary policy announcement and U.S. inflation data, with expectations of no changes in the ECB's stance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ORCL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ORCL
Wall Street analysts forecast ORCL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ORCL is 309.59 USD with a low forecast of 180.00 USD and a high forecast of 400.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
34 Analyst Rating
25 Buy
9 Hold
0 Sell
Moderate Buy
Current: 142.820
Low
180.00
Averages
309.59
High
400.00
Current: 142.820
Low
180.00
Averages
309.59
High
400.00
About ORCL
Oracle Corporation offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. The Company operates through three businesses: cloud and license, hardware and service. Its cloud and license business is engaged in the sale, marketing and delivery of its enterprise applications and infrastructure technologies through cloud and on-premise deployment models including its cloud services and license support offerings, and its cloud license and on-premise license offerings. Its hardware business provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management and other hardware-related software to support diverse IT environments. Its services business provides services to customers and partners to help maximize the performance of their investments in Oracle applications and infrastructure technologies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
OCI Enhances Patient and Provider Experiences for Five Ontario Hospitals
- Infrastructure Migration: The five hospitals improved their electronic health record system's performance by migrating to OCI, achieving a 71% reduction in page load times and a 46% decrease in login response times, significantly enhancing clinician efficiency and patient care quality.
- Enhanced Data Security: With the migration to OCI, the hospitals have achieved higher data security and real-time patient information delivery, ensuring continuity of care and overall system resilience, which supports a better patient experience.
- AI Technology Pilot: TSSO is piloting the Oracle Health Clinical AI Agent with select physicians, which can automatically generate draft clinical notes, reducing administrative burdens on doctors and allowing them to focus more on patient care, with plans to expand to more physicians in 2026.
- Strategic Vision Realization: TSSO is committed to providing people-centered care, and the migration to OCI lays the groundwork for this vision, supporting smarter healthcare decisions and a better patient-focused experience.
See More
Oracle Stock Upgraded to Buy by DA Davidson
- Upgrade Announcement: DA Davidson upgraded Oracle's rating from Neutral to Buy while maintaining a $180 price target, reflecting confidence in the company's growth prospects, particularly in light of its $300 billion agreement with OpenAI.
- Impact of OpenAI Restructuring: Analysts believe that the restructuring of OpenAI will allow it to re-emerge as Google's top competitor in the AI space, a shift that is expected to directly benefit Oracle by enhancing its market position and revenue potential.
- Technical Analysis: Although Oracle's stock is currently trading below all key moving averages, indicating ongoing bearish pressure, the RSI at 27.25 suggests a potential bounce, prompting investors to be cautious of persistent selling pressure.
- Support and Resistance Levels: Oracle's key support is at $154.50, while resistance is at $163.50; a failure to hold the support level could signal further declines, whereas a break above resistance might indicate a reversal opportunity.
See More
Software Stocks Rebound, AppLovin Surges 14%
- Software Stock Rebound: Following last week's severe selloff, the iShares Expanded Tech-Software Sector ETF (NYSE:IGV) jumped over 3% on Monday, marking its strongest daily gain since late April 2025, indicating renewed investor interest in software stocks and a potential recovery in market confidence.
- Nasdaq Outperformance: The Nasdaq 100 climbed 1%, significantly outperforming broader Wall Street, while the S&P 500 added 0.7%, suggesting that the strong rebound in tech stocks is driving overall market gains and may attract more capital inflows.
- Individual Stock Surge: AppLovin Corp. (NASDAQ:APP) surged more than 14% after logging four consecutive weekly declines, reflecting optimistic market sentiment regarding its future growth potential, which could draw more investor attention to the company.
- Commodity Market Recovery: Oil prices rose over 2% to $64.6 a barrel, while gold rebounded 2.5% to $5,090 an ounce, and silver soared over 6% to $82 an ounce, indicating an improvement in market risk appetite that may positively impact related industries.
See More
US Stocks Rebound as Tech Shares Recover
- Market Recovery: The S&P 500 Index rose by 0.46%, the Dow Jones Industrial Average increased by 0.09%, and the Nasdaq 100 climbed by 0.61%, indicating a rebound in the market driven by recovering tech and chipmaker stocks, reflecting investor confidence in economic growth.
- Mining Stocks Surge: Gold prices increased by over 1% and silver prices jumped more than 6%, boosting mining stocks with Coeur Mining up over 6% and Freeport McMoRan up more than 5%, suggesting rising investor demand for precious metals amid inflation concerns.
- Positive Earnings Outlook: Over 79% of S&P 500 companies that reported earnings exceeded expectations, with Q4 earnings growth projected at 8.4%, marking the tenth consecutive quarter of year-over-year growth, indicating sustained corporate profitability that could further drive stock market gains.
- Economic Data Focus: The market is closely watching upcoming employment and inflation data, with January nonfarm payrolls expected to rise by 69,000 and the unemployment rate to remain at 4.4%, as these figures will influence investor expectations regarding future monetary policy, potentially leading to market volatility.
See More
U.S. Stocks Mostly Higher, Nasdaq Up Over 1%
- Nasdaq Performance: The Nasdaq Composite rose by 1.15% to 23,295.01 on Monday, indicating strong performance in technology stocks and reflecting increased investor confidence in the tech sector.
- Dow Jones Decline: The Dow Jones Industrial Average fell slightly by 0.07% to 50,078.58, suggesting a relative weakness in traditional sectors, which may affect overall market sentiment.
- Sally Beauty Earnings Beat: Sally Beauty Holdings Inc (NYSE:SBH) reported an adjusted EPS of 48 cents for Q1, surpassing market expectations of 46 cents, with quarterly sales of $943.168 million exceeding the anticipated $940.150 million, demonstrating the company's resilience in a competitive market.
- Commodity Market Movements: On Monday, oil prices increased by 0.8% to $64.05, gold rose by 2.2% to $5,088.80, and silver surged by 7.9% to $82.94, reflecting heightened demand for safe-haven assets, which could influence future investment strategies.
See More
Class Action Lawsuit Filed Against Oracle Corporation
- Lawsuit Background: Bronstein, Gewirtz & Grossman LLC has initiated a class action lawsuit against Oracle Corporation and certain officers, seeking damages for investors who purchased Oracle securities between June 12, 2025, and December 16, 2025, highlighting serious concerns over the company's financial transparency.
- Allegations: The complaint alleges that Oracle failed to disclose that its AI infrastructure strategy would lead to significant increases in capital expenditures without corresponding near-term revenue growth, indicating major mismanagement in financial strategy.
- Financial Risks: It also points out that the increased spending poses serious risks to Oracle's debt, credit rating, free cash flow, and ability to fund projects, reflecting a lack of effective financial risk management that could impact long-term growth.
- Investor Action: Investors are encouraged to apply to be lead plaintiffs by April 6, 2026, indicating that the case may attract significant investor attention, potentially affecting Oracle's market reputation and stock performance.
See More
OCI Enhances Patient and Provider Experiences for Five Ontario Hospitals
- Infrastructure Migration: The five hospitals improved their electronic health record system's performance by migrating to OCI, achieving a 71% reduction in page load times and a 46% decrease in login response times, significantly enhancing clinician efficiency and patient care quality.
- Enhanced Data Security: With the migration to OCI, the hospitals have achieved higher data security and real-time patient information delivery, ensuring continuity of care and overall system resilience, which supports a better patient experience.
- AI Technology Pilot: TSSO is piloting the Oracle Health Clinical AI Agent with select physicians, which can automatically generate draft clinical notes, reducing administrative burdens on doctors and allowing them to focus more on patient care, with plans to expand to more physicians in 2026.
- Strategic Vision Realization: TSSO is committed to providing people-centered care, and the migration to OCI lays the groundwork for this vision, supporting smarter healthcare decisions and a better patient-focused experience.
See More
Oracle Stock Upgraded to Buy by DA Davidson
- Upgrade Announcement: DA Davidson upgraded Oracle's rating from Neutral to Buy while maintaining a $180 price target, reflecting confidence in the company's growth prospects, particularly in light of its $300 billion agreement with OpenAI.
- Impact of OpenAI Restructuring: Analysts believe that the restructuring of OpenAI will allow it to re-emerge as Google's top competitor in the AI space, a shift that is expected to directly benefit Oracle by enhancing its market position and revenue potential.
- Technical Analysis: Although Oracle's stock is currently trading below all key moving averages, indicating ongoing bearish pressure, the RSI at 27.25 suggests a potential bounce, prompting investors to be cautious of persistent selling pressure.
- Support and Resistance Levels: Oracle's key support is at $154.50, while resistance is at $163.50; a failure to hold the support level could signal further declines, whereas a break above resistance might indicate a reversal opportunity.
See More
Software Stocks Rebound, AppLovin Surges 14%
- Software Stock Rebound: Following last week's severe selloff, the iShares Expanded Tech-Software Sector ETF (NYSE:IGV) jumped over 3% on Monday, marking its strongest daily gain since late April 2025, indicating renewed investor interest in software stocks and a potential recovery in market confidence.
- Nasdaq Outperformance: The Nasdaq 100 climbed 1%, significantly outperforming broader Wall Street, while the S&P 500 added 0.7%, suggesting that the strong rebound in tech stocks is driving overall market gains and may attract more capital inflows.
- Individual Stock Surge: AppLovin Corp. (NASDAQ:APP) surged more than 14% after logging four consecutive weekly declines, reflecting optimistic market sentiment regarding its future growth potential, which could draw more investor attention to the company.
- Commodity Market Recovery: Oil prices rose over 2% to $64.6 a barrel, while gold rebounded 2.5% to $5,090 an ounce, and silver soared over 6% to $82 an ounce, indicating an improvement in market risk appetite that may positively impact related industries.
See More
US Stocks Rebound as Tech Shares Recover
- Market Recovery: The S&P 500 Index rose by 0.46%, the Dow Jones Industrial Average increased by 0.09%, and the Nasdaq 100 climbed by 0.61%, indicating a rebound in the market driven by recovering tech and chipmaker stocks, reflecting investor confidence in economic growth.
- Mining Stocks Surge: Gold prices increased by over 1% and silver prices jumped more than 6%, boosting mining stocks with Coeur Mining up over 6% and Freeport McMoRan up more than 5%, suggesting rising investor demand for precious metals amid inflation concerns.
- Positive Earnings Outlook: Over 79% of S&P 500 companies that reported earnings exceeded expectations, with Q4 earnings growth projected at 8.4%, marking the tenth consecutive quarter of year-over-year growth, indicating sustained corporate profitability that could further drive stock market gains.
- Economic Data Focus: The market is closely watching upcoming employment and inflation data, with January nonfarm payrolls expected to rise by 69,000 and the unemployment rate to remain at 4.4%, as these figures will influence investor expectations regarding future monetary policy, potentially leading to market volatility.
See More
U.S. Stocks Mostly Higher, Nasdaq Up Over 1%
- Nasdaq Performance: The Nasdaq Composite rose by 1.15% to 23,295.01 on Monday, indicating strong performance in technology stocks and reflecting increased investor confidence in the tech sector.
- Dow Jones Decline: The Dow Jones Industrial Average fell slightly by 0.07% to 50,078.58, suggesting a relative weakness in traditional sectors, which may affect overall market sentiment.
- Sally Beauty Earnings Beat: Sally Beauty Holdings Inc (NYSE:SBH) reported an adjusted EPS of 48 cents for Q1, surpassing market expectations of 46 cents, with quarterly sales of $943.168 million exceeding the anticipated $940.150 million, demonstrating the company's resilience in a competitive market.
- Commodity Market Movements: On Monday, oil prices increased by 0.8% to $64.05, gold rose by 2.2% to $5,088.80, and silver surged by 7.9% to $82.94, reflecting heightened demand for safe-haven assets, which could influence future investment strategies.
See More
Class Action Lawsuit Filed Against Oracle Corporation
- Lawsuit Background: Bronstein, Gewirtz & Grossman LLC has initiated a class action lawsuit against Oracle Corporation and certain officers, seeking damages for investors who purchased Oracle securities between June 12, 2025, and December 16, 2025, highlighting serious concerns over the company's financial transparency.
- Allegations: The complaint alleges that Oracle failed to disclose that its AI infrastructure strategy would lead to significant increases in capital expenditures without corresponding near-term revenue growth, indicating major mismanagement in financial strategy.
- Financial Risks: It also points out that the increased spending poses serious risks to Oracle's debt, credit rating, free cash flow, and ability to fund projects, reflecting a lack of effective financial risk management that could impact long-term growth.
- Investor Action: Investors are encouraged to apply to be lead plaintiffs by April 6, 2026, indicating that the case may attract significant investor attention, potentially affecting Oracle's market reputation and stock performance.
See More
